跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,799 条关于
“JLL”
全部
4,799
临床试验
4,261
药物
153
机构
30
资讯
355
3个月前
U.S. Lab Property Market Shows Early Recovery Signs as Landlords Pivot to AI and Biomanufacturing Tenants
28天前
Gillette Acquires South Boston Life Science Site for $99.29M, Pledges Near-$1B Investment
去年
Ibrutinib/Venetoclax Shows Survival Benefit in High-Risk CLL/SLL
去年
SOHO 2024: Advancements in ALL, CML, and CLL Treatment Strategies
去年
Lilly's Jaypirca Shows Promise in BTK Inhibitor-Pretreated CLL/SLL
9个月前
Lisaftoclax Demonstrates 62.5% Response Rate in BTK-Refractory CLL/SLL Patients
2年前
Zanubrutinib Combination Therapies Show Promise in High-Risk CLL/SLL Treatment
5年前
Liso-cel Plus Ibrutinib Shows Promise in Relapsed/Refractory CLL/SLL: Primary Results from TRANSCEND CLL 004 Study
去年
Zanubrutinib Demonstrates Durable Efficacy and Favorable Safety in CLL/SLL Treatment
去年
AMPLIFY Trial Shows Promise: Acalabrutinib Combinations Outperform Chemoimmunotherapy in CLL/SLL Treatment
第 1 页,共 36 页
上一页
下一页